Hematology analyzers can now use computer vision technologies to recognize, enumerate, differentiate, and count blood cells.
Increasing adoption of automated hematology instruments, rising technological advancements, and integration of new techniques in modern hematology analyzers are driving the market growth worldwide.
Delivering technology that lowers manual review rates, provides true standardization, optimizes end-to-end workflow and increases efficiency, the vendors are aiding faster and better diagnostics, while providing clinicians with the information they need to make treatment decisions earlier and with more confidence.
There is a significant market shift of hematology diagnostics instruments from manual testing to semi-automated or fully automated instruments, with manufacturers competing mainly on the number of parameters measured, reagents consumed, style, and price.
The newer generation of hematology analyzers may be designed to face emerging needs while maintaining a high degree in the quality of testing.
The modern hematology instruments represent a great advance in technical capabilities, providing high-throughput and high-resolution measurements of a single RBC.
Hematology testing may not be characterized as much by technology innovation but in finding ways to perform higher volumes of highly accurate routine and follow-up tests.
Increasing instances of partnership among hematology instruments and consumables manufacturers is one of the recent trends in the hematology instruments and reagents market.
There is a continued focus on addition of new parameters and development of point-of-care instrumentation in hematology allowing for evaluation of blood cells with great accuracy and precision.
Technological advances being incorporated into hematology analyzers are now allowing access to more cellular information than before.